Asuragen Grants Armored RNA® Technology License to BD
07:30 EDT 19 Jun 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Asuragen,
Inc. announced today that it has granted BD (Becton, Dickinson and
Company), a global medical technology company, non-exclusive worldwide
rights to incorporate Armored
RNA® technology into its in vitro molecula...
Other Sources for this Article
Asuragen, Inc.
Rollie Carlson, Ph.D., 512-681-5200
President
and COO
rcarlson@asuragen.com
More From BioPortfolio on "Asuragen Grants Armored RNA® Technology License to BD"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
